Fidelity Advisor Health Care FundFACTX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$2.9B
Expense ratio
1.18%
1-year return
+33.4%
3 years, a year
-9.1%
5 years, a year
-22.8%
12-month yield
12.69%
Holdings
138
What it aims to do.
Fidelity Advisor Health Care Fund seeks capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY ELI LILLY and CO | 6.93% |
| DHR Danaher Corp | 6.79% |
| JNJ JOHNSON and JOHNSON | 5.67% |
| TMO Thermo Fisher Scientific Inc | 3.62% |
| UNH Unitedhealth Group Inc | 3.02% |
| BSX Boston Scientific Corp | 2.79% |
| Ascendis Pharma A/S | 2.70% |
| ALNY Alnylam Pharmaceuticals Inc | 2.44% |
| GILD Gilead Sciences Inc | 2.27% |
| ABBV Abbvie Inc | 2.23% |
More on FACTX.
- FACTX overview
- FACTX holdings
- FACTX risk
- FACTX costs
- FACTX money in and out
- FACTX share classes
- Compare FACTX with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.